Erratum to: Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours | Zendy

AI Assistant Blog Pricing

Erratum to: Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.